Pucotenlimab

Pucotenlimab (HX008) is a humanized immunoglobulin G4 (IgG4) anti programmed cell death protein 1 (anti-PD-1) monoclonal antibody. Pucotenlimab can be used for the research of tumor[1].

Product Specifications

CAS Number

[2403647-03-8]

Product Name Alternative

HX008

UNSPSC

12352203

Target

PD-1/PD-L1

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/pucotenlimab.html

Purity

97.00

Solubility

10 mM in DMSO

Smiles

[Pucotenlimab]

Molecular Weight

(144.8 kDa)

References & Citations

[1]Rujiao Liu, et al. Phase I study of pucotenlimab (HX008), an anti-PD-1 antibody, for patients with advanced solid tumors. Ther Adv Med Oncol. 2021 May 31;13:17588359211020528.